Australia Diagnostic Imaging and Pathology Services Market is Expected to Reach around AUD 9.6 Billion by 2023

Ken Research

GURUGRAM, India, January 9, 2019 /PRNewswire/ --

Australia diagnostic imaging and pathology services market segmentation by requesting provider (GP, Specialist, Allied Health and Dentist), by type of test (Radiology Tests (Ultrasound, CT Scan, Diagnostic Radiology, MRI, Nuclear Medicine Imaging and Others) and Pathology Tests (Chemical, Microbiology, Tissue Pathology, Heamtology, Patient Episode Initiation, Immunology and Others)) and by state (NSW, VIC, QLD, WA, SA, TAS, ACT and NT). The report also covers the market share of leading players in the diagnostic imaging market as well as the pathology services market, company profile of major players in diagnostic imaging and pathology services (I-MED Radiology, Sonic Healthcare, Primary Health Care, Integral Diagnostic, Capitol Health Limited, Qscan Radiology Clinics, PRP Diagnostic Imaging, Benson Radiology, Australian Clinical Labs, SA Pathology)  

• Ultrasound followed by CT Scans and Diagnostic Radiology Tests are likely to remain the most recommended tests in Australia Diagnostic Imaging Market.
• Pathology services market is likely to be dominated by chemical tests, followed by microbiology and tissue pathology.  
• New South Wales will have the mammoth share in the overall clinical services market, followed by Victoria and Queensland.

Australia Clinical Services Market Stage and Future Consolidation: The Australia clinical services (diagnostic imaging and pathology services) market is in its late growth stage. The market is highly competitive and fragmented owing to the presence of a number of players. Diagnostic imaging services market is likely to continue its domination of the overall clinical services market with majority of revenue share. The market is likely to witness aggressive expansion by the big players through organic growth in number of centres. The expansion strategy of some of the mid-level or big players in the market will also involve acquisition of some smaller players that are concentrated in a certain area or region of the country.

     (Logo: https://mma.prnewswire.com/media/661352/Ken_Research_Logo.jpg )

Medicare Benefits and Bulk Billing are Major Growth Drivers: The medi-care benefits provided by the government are one of the primary growth drivers for clinical services market in the country. The benefits include almost all the major diagnostic and pathology tests. Recently, the government has added cardiac and prostrate MRI which will further boost the revenues for the diagnostic imaging market. Announcement of indexations in schedule fee by Medicare will also potentially aid in market growth in the near future. In the pathology services market the reversal to the cuts in bulk bill incentives will be a major growth driver for industry in Australia. There is a rising trend of outsourcing pathology tests in public hospitals to private clinics or service providers. This trend coupled with the implementation of national screening programs has significantly augmented the revenues of the pathology service market in Australia.